Researchers link vitamin B12 to ALS treatment
Posted May 13, 2003 in ALS Research
TOKUSHIMA: A group of University of Tokushima researchers has discovered that methylcobalamin, a type of vitamin B12, could slow down the attack of amyotrophic lateral sclerosis (ALS), a progressive neuro-degenerative illness also known as Lou Gehrig's disease.
Researchers say methylcobalamin treatment could prolong the life of severe ALS patients. The research group, led by Ryuji Kaji, professor of neurology at the University of Tokushima, plans to present the results at a meeting of the Japanese Society of Neurology in Yokohama on Thursday. (Kyodo News)